Marburg virus, Rwanda
Scientists in Nigeria are expanding their research into deadly Lassa fever with the launch of a pioneering study designed to ...
More information: Gabrielle Scher et al, Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease, npj Vaccines (2024). DOI: 10.1038 ...
The vaccine, named LASSARAB, uses a deactivated rabies virus platform to deliver antigens to protect against the Lassa fever virus. Lassa fever is a severe hemorrhagic disease that is endemic ...
Lassa fever, a disease otherwise referred to as Lassa hemorrhagic fever caused by the Lassa virus, is primarily ...
Nigeria: Ten Years After Ebola - Learnings for Lassa Fever, 'Lassa-X' and Pandemic Preparedness Lead
modelled "Lassa-X," a hypothetical Lassa-related virus with higher transmissibility and virulence, to assess vaccination strategies within the 100 Days Mission. Over the next ten years ...
Officials confirmed that the medical student, who had been in Rwanda as part of their studies, showed no symptoms of the Marburg virus and tested negative through a PCR test. The student had come ...
The Coalition for Epidemic Preparedness Innovations (CEPI) said it has invested over $250 million in Lassa fever research since 2017 for the development of a vaccine against the deadly disease.
(CEPI) has disclosed that a significant amount of over $250 million has been invested to develop Lassa fever vaccine to combat a highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback